Detection of both an antibody and an antigen in a single sample aliquot

• US 5,627,026 A
• Filed: 12/27/1994
• Issued: 05/06/1997
• Est. Priority Date: 07/14/1988
• Status: Expired due to Term

• Current Assignee: IDEXX Laboratories Incorporated
• Original Assignee: IDEXX Laboratories Incorporated
• Inventors: O'Connor, Thomas P., Tonelli, Quentin J.
• Primary Examiner(s): Knode, Marian C.
• Assistant Examiner(s): Wortman, Donna C.
• Application Number:
  US08/364,432
• Time in Patent Office: 861 Days
• Field of Search: 435/5, 435/7.4, 435/7.1, 435/235.1, 435/805, 436/518, 436/548, 436/544, 436/820, 436/501, 436/536, 436/540, 436/545, 436/810, 436/811, 530/387.1, 530/388.3, 530/388.35
• US Class Current: 435/5
• CPC Class Codes: G01N 33/54306 Solid-phase reaction mechanisms
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 33/56983 Viruses
• CPC Class Codes: G01N 33/56988 HIV or HTLV
• CPC Class Codes: G01N 33/576 for hepatitis
• CPC Class Codes: Y10S 436/82 Hepatitis associated antigens and antibodies

Abstract

A method for detecting the presence of antibody to FIV in a biological sample. The method includes the steps of providing a first antigen having a first epitope recognized by the antibody, the first antigen being detectable; contacting the first antigen with the sample under conditions under which the antibody can bind to the first antigen to form an immune complex; and detecting the immune complex. An ELISA test for FIV, using purified FIV antigen, is also described.

Claims

1. A method for detecting an antibody and an antigen in a single biological sample, said method comprising:

(a) providing an antigen which selectively forms a first immune complex with a sample antibody, said antigen being directly bound to a solid support at a first location;

(b) providing an antibody which selectively forms a second immune complex with a sample antigen, said antibody being directly bound to said solid support at a second location;

(c) contacting said first location on said solid support with at least a portion of a biological sample under conditions whereby said first immune complex can form and contacting said second location on said solid support with at least a portion of said sample under conditions whereby said second immune complex can form;

(d) washing unbound material from said first location and from said second location; and

(e) separately detecting whether said first immune complex is formed and whether said second immune complex is formed, said first immune complex being detected with a labelled antigen which selectively binds to said first complex and said second immune complex being detected by adding a labelled antibody which selectively binds to said second complex, said labelled antibody being presented to both said first and said second locations.

2. The method of claim 1, wherein said detection of said first immune complex and detection of said second immune complex occur simultaneously.

3. The method of claim 1, wherein said antigen provided in Step (a) is a virus or a viral antigen and said antibody provided in step (b) is capable of selectively forming an immune complex with a virus or a viral antigen.

4. The method of claim 3, wherein each of said viruses is a feline virus.

5. The method of claim 3, wherein each of said viruses is a human virus.

6. The method of claim 5, wherein each of said human viruses is chosen, independently, from the group consisting of a human immunodeficiency virus, a human T-lymphotropic virus, or a hepatitis virus.

7. A method for detecting an antibody to an antigen of a first feline pathogen and an antigen of a second feline pathogen in a single biological sample, said first and second feline pathogens being independently selected from the group consisting of Feline Leukemia Virus (FeLV) and Feline Immune Deficiency Virus (FIV), said method comprising:

(a) providing an antigen which selectively forms a first immune complex with a sample antibody, said antigen being directly bound to a solid support at a first location;

(b) providing an antibody which selectively forms a second immune complex with a sample antigen, said antibody being directly bound to said solid support at a second location;

(c) contacting said first location on said solid support with at least a portion of a biological sample under conditions whereby said first immune complex can form and contacting said second location on said solid support with at least a portion of said sample under conditions whereby said second immune complex can form;

(d) washing unbound material from said first location and from said second location; and

(e) separately detecting whether said first immune complex is formed and whether said second immune complex is formed, said first immune complex being detected with a labelled antigen which selectively binds to said first complex and said second immune complex being detected by adding a labelled antibody which selectively binds to said second complex, said labelled antibody being presented to both said first and said second locations.

8. The method of claim 7 in which said first feline pathogen is FIV and said second feline pathogen is FeLV.

9. A kit comprising:

a) a solid support comprising an antigen which is capable of selectively forming a first immune complex with a sample antibody, said antigen being directly bound to a solid support at a first location; and

an antibody, said antibody being capable of selectively forming a second immune complex with a sample antigen, said antibody being directly bound to said solid support at a second location,

wherein said locations are positioned so that antigen may be contacted with at least a portion of a biological sample whereby said first immune complex can form and said antibody may be contacted with at least a portion of said sample, whereby said second immune complex can form;

b) a complex detector comprising a labelled antigen which selectively binds to said first immune complex, and

c) a labelled antibody which selectively binds to said second immune complex when said labelled antibody is presented to both said first and said second locations.

10. The kit of claim 9, wherein said antigen bound at said first location is a virus or a viral antigen and said antibody bound at said second location is capable of selectively forming an immune complex with a virus or a viral antigen.

11. The kit of claim 10, wherein each of said viruses is a feline virus.

12. The kit of claim 10, wherein each of said viruses is a human virus.

13. The kit of claim 12, wherein each of said human viruses is chosen, independently, from the group consisting of a human immunodeficiency virus, a human T-lymphotropic virus, or a hepatitis virus.

14. A kit comprising:

a) a solid support comprising an antigen of a first feline pathogen, wherein said antigen is capable of selectively forming a first immune complex with a sample antibody, said antigen being directly bound to a solid support at a first location; and

an antibody to an antigen of a second feline pathogen , wherein said antibody is capable of selectively forming a second immune complex with a sample antigen, said antibody being directly bound to said solid support at a second location,

wherein said antigen may be contacted with at least a portion of a biological sample under conditions whereby said first immune complex can form and said antibody may be contacted with at least a portion of said sample, whereby said second immune complex can form;

b) a complex detector comprising a labelled antigen which selectively binds to said first immune complex, and

c) a labelled antibody which selectively binds to said second immune complex when said labelled antibody is presented to both said first and said second locations.

15. The kit of claim 14 in which said first feline pathogen is FIV and said second feline pathogen is FeLV.